GB0725214D0 - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
GB0725214D0
GB0725214D0 GBGB0725214.1A GB0725214A GB0725214D0 GB 0725214 D0 GB0725214 D0 GB 0725214D0 GB 0725214 A GB0725214 A GB 0725214A GB 0725214 D0 GB0725214 D0 GB 0725214D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0725214.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Karo Pharma AB
Original Assignee
Karo Bio AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karo Bio AB filed Critical Karo Bio AB
Priority to GBGB0725214.1A priority Critical patent/GB0725214D0/en
Publication of GB0725214D0 publication Critical patent/GB0725214D0/en
Priority to PCT/EP2008/068274 priority patent/WO2009080835A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
GBGB0725214.1A 2007-12-24 2007-12-24 Pharmaceutical compounds Ceased GB0725214D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0725214.1A GB0725214D0 (en) 2007-12-24 2007-12-24 Pharmaceutical compounds
PCT/EP2008/068274 WO2009080835A1 (en) 2007-12-24 2008-12-23 Thyromimetric compounds in treatment of disease related to sonic hedgehog signalling

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0725214.1A GB0725214D0 (en) 2007-12-24 2007-12-24 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
GB0725214D0 true GB0725214D0 (en) 2008-02-06

Family

ID=39092361

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0725214.1A Ceased GB0725214D0 (en) 2007-12-24 2007-12-24 Pharmaceutical compounds

Country Status (2)

Country Link
GB (1) GB0725214D0 (en)
WO (1) WO2009080835A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2590951B1 (en) 2010-07-09 2015-01-07 Pfizer Limited Benzenesulfonamides useful as sodium channel inhibitors
US9096500B2 (en) 2010-07-12 2015-08-04 Pfizer Limited Acyl sulfonamide compounds
CA2804351A1 (en) 2010-07-12 2012-01-19 Pfizer Limited Chemical compounds
EP2593432B1 (en) 2010-07-12 2014-10-22 Pfizer Limited N-sulfonylbenzamide derivatives useful as voltage gated sodium channel inhibitors
EP2593427B1 (en) 2010-07-12 2014-12-24 Pfizer Limited Sulfonamide derivatives as nav1.7 inhibitors for the treatment of pain
CA2800971A1 (en) 2010-07-12 2012-01-19 Pfizer Limited Chemical compounds
CA2837199A1 (en) * 2011-05-23 2012-11-29 Elan Pharmaceuticals, Inc. Cinnoline compounds as inhibitor of lrrk2 kinase activity
ES2593533T3 (en) 2011-12-15 2016-12-09 Pfizer Limited Sulfonamide derivatives
WO2013128927A1 (en) * 2012-02-29 2013-09-06 国立大学法人東京医科歯科大学 Novel androgen receptor antagonist
EP2695611B1 (en) 2012-08-06 2014-10-01 Dr. August Wolff GmbH & Co. KG Arzneimittel Eprotirome for use in the prevention and/or treatment of hair disorders and compositions thereof
WO2017184604A1 (en) 2016-04-18 2017-10-26 Ifm Therapeutics, Inc Compounds and compositions for treating conditions associated with nlrp activity
US11718631B2 (en) * 2017-10-17 2023-08-08 Novartis Ag Sulphonamides and compositions thereof for treating conditions associated with NLRP activity
EP4240722A1 (en) * 2020-11-06 2023-09-13 Aligos Therapeutics, Inc. Oxindoles and methods of use thereof
CN114685430B (en) * 2022-03-18 2023-07-21 浙江大学 Fenbendazole analogue, and preparation method and application thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993024442A1 (en) * 1992-05-29 1993-12-09 Yamanouchi Pharmaceutical Co., Ltd. Medicine containing benzoic acid derivative and novel benzoic acid derivative
US5736576A (en) * 1996-06-04 1998-04-07 Octamer, Inc. Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity
EP1003498A4 (en) * 1997-03-26 2004-07-14 Biosource Tech Inc Di-aryl ethers and their derivatives as anti-cancer agents
ES2230864T3 (en) * 1998-07-24 2005-05-01 Teijin Limited DERIVATIVES OF ANTRANILIC ACID.
GB9828442D0 (en) * 1998-12-24 1999-02-17 Karobio Ab Novel thyroid receptor ligands and method II
US6638977B1 (en) * 1999-11-19 2003-10-28 Corvas International, Inc. Plasminogen activator inhibitor antagonists
EP1256341A4 (en) * 2000-02-15 2004-12-08 Teijin Ltd Cancer remedy comprising anthranilic acid derivative as active ingredient
GB0015205D0 (en) * 2000-06-21 2000-08-09 Karobio Ab Bioisosteric thyroid receptor ligands and method
US7321065B2 (en) * 2003-04-18 2008-01-22 The Regents Of The University Of California Thyronamine derivatives and analogs and methods of use thereof
GB0406380D0 (en) * 2004-03-22 2004-04-21 Karobio Ab Novel pharmaceutical compositions
EA201890903A9 (en) * 2004-09-02 2021-11-10 Дженентек, Инк. COMPOUNDS OF PYRIDYL INHIBITORS OF SIGNAL TRANSMISSION BY HEDGEHOG PROTEIN, METHOD FOR THEIR PREPARATION, COMPOSITION AND METHODS FOR TREATING CANCER AND INHIBITING ANGIOGENESIS AND SIGNAL PATH OF HEDGEHOG IN FLAGS
WO2006076376A1 (en) * 2005-01-11 2006-07-20 Medicinova, Inc. Topical treatment of solid tumors and ocular neovascularization
WO2006123229A2 (en) * 2005-05-19 2006-11-23 Orchid Research Laboratories Limited Novel heterocyclic derivatives
GB0513692D0 (en) * 2005-07-04 2005-08-10 Karobio Ab Novel pharmaceutical compositions

Also Published As

Publication number Publication date
WO2009080835A1 (en) 2009-07-02

Similar Documents

Publication Publication Date Title
GB0709031D0 (en) Pharmaceutical compounds
IL201366A0 (en) Pharmaceutical compounds
GB0721095D0 (en) Pharmaceutical compounds
ZA201104336B (en) Pharmaceutical compounds
GB0707087D0 (en) Pharmaceutical compounds
GB0816372D0 (en) Pharmaceutical compounds
GB0820819D0 (en) Pharmaceutical compounds
GB0801416D0 (en) Pharmaceutical compounds
GB0816371D0 (en) Pharmaceutical compounds
GB0725214D0 (en) Pharmaceutical compounds
GB0704932D0 (en) Pharmaceutical compounds
GB0812969D0 (en) Pharmaceutical compounds
GB0721669D0 (en) Pharmaceutical compounds
PL2271618T3 (en) Pharmaceutical compounds
GB0816370D0 (en) Pharmaceutical compounds
GB0810857D0 (en) Pharmaceutical compounds
GB0718045D0 (en) Pharmaceutical compound
GB0608184D0 (en) Pharmaceutical compounds
GB0608176D0 (en) Pharmaceutical Compounds
GB0608264D0 (en) Pharmaceutical compounds
GB0608175D0 (en) Pharmaceutical Compounds
GB0711346D0 (en) Pharmaceutical compounds
GB0707088D0 (en) Pharmaceutical compounds
GB0711345D0 (en) Pharmaceutical compounds
GB0707086D0 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)